Astegolimab or Efmarodocokin Alfa in Patients With Severe COVID-19 Pneumonia: A Randomized, Phase 2 Trial. uri icon

authors

  • Waters, Michael
  • Rosenberger, Carrie M
  • Pappu, Rajita
  • Wang, Yehong
  • Wenhui (Vivian) Zhang, PhD, MS
  • Brooks, Logan
  • Cheung, Dorothy
  • Galanter, Joshua
  • Chen, Hubert
  • Mohan, Divya
  • Peck, Melicent C
  • McKinnell, James A
  • Kalil, Andre C
  • Martin, Greg S
  • Buchman, Timothy G
  • Theess, Wiebke
  • Yang, Xiaoying
  • Lekkerkerker, Annemarie N
  • Staton, Tracy

publication date

  • January 1, 2022